March 15, 2022
CAMBRIDGE, Mass. & PORTLAND, Ore. -- Ultivue, Inc. an industry leader in multiplexing tools and novel image analysis solutions for tissue biomarker studies, and Sirona Dx, a technical contract research organization (CRO), providing advanced, single cell proteomics and genomics services to accelerate the pace of immunotherapy and targeted therapy development, announced a co-marketing agreement to [...]
ICSPI Partners With DKSH in Asia Pacific
March 14, 2022
Zurich – DKSH Business Unit Technology has entered a partnership with ICSPI, an innovative manufacturer of single-chip scanning probe microscopes for educational, research and industrial applications. DKSH will provide sales, marketing, and after-sales services in Thailand, Vietnam, Malaysia, Philippines, Indonesia, Singapore, Australia, New Zealand, Korea and Taiwan. ICSPI is on a mission to bring robust, [...]
BIOKÉ and Applied Cells announce a distribution agreement for the Benelux countries
March 14, 2022
LEIDEN - BIOKÉ announced it has signed a distribution agreement with Applied Cells Inc to distribute the MARS® technology in the Netherlands, Belgium, and Luxembourg (Benelux), effective immediately. Applied Cells is a leading provider of cell preparation and isolation solutions for tumor biology, cell therapy, and genomics research. Their proprietary innovative MARS platform, short-named after [...]
Etaluma Supports New RegeneratOR Test Bed with LS460 Microscope
March 14, 2022
San Diego, Calif. – Etaluma is collaborating with the RegeneratOR Test Bed, a new regenerative medicine endeavor in North Carolina, by providing its technology to help support start-up and early-stage companies in the regenerative medicine space. This partnership will help accelerate the growth of these scale up companies by providing a unique technology that optimizes [...]
AYOXXA receives fresh capital for commercial growth
March 14, 2022
Financing round led by Prosnav Capital, a strategic international investor based in Luxembourg and Hong Kong, and supported by investment from a group of continuing shareholders Financing accelerates the company's development into a global leader in proteomics and provides direct access to Asian market opened through broad network of Prosnav Capital New management team appointed [...]
Hitachi High-Tech Announces Executive Changes
March 14, 2022
Tokyo – Hitachi High-Tech Corporation today announced the change of Executive Officers as follows. Executive Officers (Effective April 1, 2022) The underlined parts are changes effective April 1, 2022. Title Name Responsibilities [...]
Illumina Welcomes Carissa Rollins as Chief Information Officer
March 14, 2022
SAN DIEGO -- Illumina, Inc. (NASDAQ: ILMN) announced today that Carissa Rollins will join the company as Chief Information Officer on March 14, 2022. Rollins brings over 30 years of business technology transformation and digital and consumerization strategy experience. Rollins will report to Chief Executive Officer, Francis deSouza. Most recently, Rollins was the Chief Information [...]
SOPHiA GENETICS and REALM IDx Sign Letter of Intent to Collaborate in Accelerating Cancer Research
March 14, 2022
The intended collaboration aims to help improve patient care by enhancing next-generation sequencing research for cancer care and expanding data sources for precision medicine. BOSTON & ALISO VIEJO, Calif., United States and LAUSANNE, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH) and REALM IDx announced today that they signed a letter of intent to collaborate in the co-development [...]
Element Launches the AVITI™ System to Democratize Access to Genomics
March 14, 2022
Element Biosciences Inc., developer of a new and disruptive DNA sequencing platform, today announced the commercial launch of the Element AVITI™ System, a benchtop sequencer offering an unrivaled combination of performance, cost, and flexibility. Element’s proprietary Avidity Sequencing™ chemistries enable exceptional accuracy and cost efficiency that is unmatched by other benchtop systems. The AVITI™ System operates [...]
March 14, 2022
Companies Aim to Bring Together LinearDNA™ and Spindle Biotech’s Proprietary Engineered RNA Polymerase to Develop a Next-Generation, Cell-Free mRNA Production Platform STONY BROOK, N.Y. and TORONTO, CANADA – Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in cell-free, enzymatic DNA production, and Spindle Biotech Inc. (“Spindle Biotech”), a company focused on the development of [...]

